Article

Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular…

BioMed Research International · 2017 · Erhua Yao, author Jinghong Chen, author Xiaofang Zhao, author Yinyan Zheng, author Xianheng Wu, author Fei Han, author Hecheng Huang, author Ping Liang, author Jianmin Liu, author Fasheng Wu, author Lianxing Lin, author Fumio Imazeki, Academic Editor

Key facts

Title Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
First author Erhua Yao, author Jinghong Chen, author Xiaofang Zhao, author Yinyan Zheng, author Xianheng Wu, author Fei Han, author Hecheng Huang, author Ping Liang, author Jianmin Liu, author Fasheng Wu, author Lianxing Lin, author Fumio Imazeki, Academic Editor
Journal BioMed Research International
Published Jul 29, 2017
DOI 10.1155/2018/5481909
Devices mentioned K000478, K011024, K032345, K041315, K052325, K062514, K062967, K072504, K091999, K102650, K122137, K150873 and 2 more
Product codes mentioned IWB, IYE, MUJ

At a glance

  • 10–99 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature